Related Experiment Video
Updated: Oct 20, 2025

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2
Antonette Bennett1, Joshua Hull1, Nelly Jolinon2
1Department of Biochemistry & Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Adeno-associated virus (AAV) gene therapy vectors, like AAV-True Type (AAV-TT), show enhanced neurotropism. Structural and thermal analysis reveals AAV-TT
Area of Science:
- * Virology
- * Structural Biology
- * Gene Therapy
Background:
- * Adeno-associated viruses (AAV) are crucial gene transfer vectors for monogenic disorders.
- * A rationally engineered variant, AAV-True Type (AAV-TT), exhibits superior neurotropicity for central nervous system applications compared to wild-type AAV2.
- * AAV-TT's enhanced properties are linked to 14 amino acid differences from AAV2, including key residues R585S and R588T.
Purpose of the Study:
- * To structurally and thermally characterize AAV-TT and AAV2 to understand their divergent properties.
- * To investigate the impact of specific amino acid substitutions on capsid stability and function.
- * To elucidate the mechanisms behind AAV-TT's enhanced neurotropism and reduced antigenicity.
Main Methods:
- * Cryo-electron microscopy (cryo-EM) for high-resolution capsid structure determination.
- * Differential scanning fluorimetry (DSF) to assess thermal stability across various pH conditions.
- * Site-directed mutagenesis to reintroduce specific residues into AAV-TT.
Main Results:
- * Cryo-EM revealed structural perturbations in AAV-TT due to amino acid differences from AAV2.
- * AAV-TT displayed a higher melting temperature (Tm) than AAV2, indicating increased capsid stability, with optimal stability at pH 5.5.
- * Reintroducing arginines at positions 585 and 588 in AAV-TT reduced its Tm, confirming their role in stability.
Conclusions:
- * Specific amino acid differences between AAV-TT and AAV2 account for variations in cell binding, transduction, and antigenicity.
- * AAV-TT's stability and altered residue composition suggest it may bypass glycan receptor-mediated entry and possess lower immunogenicity.
- * These findings provide critical structural and thermal insights for optimizing AAV vectors in gene therapy.
More Related Videos
09:12Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
Published on: April 5, 2024
14:49A Quantitative Dot Blot Assay for AAV Titration and Its Use for Functional Assessment of the Adeno-associated Virus Assembly-activating Proteins
Published on: June 12, 2018